|
GB1188529A
(en)
*
|
1966-06-09 |
1970-04-15 |
Wellcome Found |
Pyramidine Derivatives
|
|
US3763156A
(en)
*
|
1970-01-28 |
1973-10-02 |
Boehringer Sohn Ingelheim |
2-heterocyclic amino-4-morpholinothieno(3,2-d)pyrimidines
|
|
RO62428A
(fr)
*
|
1971-05-04 |
1978-01-15 |
Thomae Gmbh Dr K |
Procede pour la preparation des thyeno-(3,2-d)-pyrimidines
|
|
GB1570494A
(en)
|
1975-11-28 |
1980-07-02 |
Ici Ltd |
Thienopyrimidine derivatives and their use as pesticides
|
|
US4703120A
(en)
*
|
1986-04-28 |
1987-10-27 |
Ortho Pharmaceutical Corporation |
Furo(3,4-d)pyrimidine-2,4-dione derivatives and intermediates thereof
|
|
US4670560A
(en)
*
|
1986-04-28 |
1987-06-02 |
Ortho Pharmaceutical Corporation |
Thienopyrimidine-2,4-dione derivatives and intermediates thereof
|
|
EP0276057B1
(de)
*
|
1987-01-21 |
1994-03-09 |
Merck & Co. Inc. |
Piperazinylpyrimidine als beta-adrenergische Rezeptoren blockierende Mittel
|
|
US5098902A
(en)
*
|
1991-03-18 |
1992-03-24 |
Warner-Lambert Company |
Method of treating neurodegenerative diseases
|
|
US6339089B2
(en)
*
|
1997-08-13 |
2002-01-15 |
Fujirebio Inc. |
Pyrimidine nucleus-containing compound and a medicament containing the same for a blood oxygen partial pressure amelioration, and a method for preparing the same
|
|
DE19944604A1
(de)
*
|
1999-09-17 |
2001-03-22 |
Merck Patent Gmbh |
Aminderivate
|
|
US6503914B1
(en)
*
|
2000-10-23 |
2003-01-07 |
Board Of Regents, The University Of Texas System |
Thienopyrimidine-based inhibitors of the Src family
|
|
AU2002364211A1
(en)
*
|
2001-12-21 |
2003-07-15 |
Bayer Pharmaceuticals Corporation |
Thienopyrimidine derivative compounds as inhibitors of prolylpeptidase, inducers of apoptosis and cancer treatment agents
|
|
AR044743A1
(es)
*
|
2002-09-26 |
2005-10-05 |
Nihon Nohyaku Co Ltd |
Herbicida, metodo de emplearlo, derivados de tienopirimidina sustituida,compuestos intermediarios, y procedimientos que se utilizan para producirlos,
|
|
GB0423653D0
(en)
|
2004-10-25 |
2004-11-24 |
Piramed Ltd |
Pharmaceutical compounds
|
|
WO2006111549A1
(de)
*
|
2005-04-21 |
2006-10-26 |
Boehringer Ingelheim International Gmbh |
Dihydrothienopyrimidine zur behandlung von entzündlichen erkrankungen
|
|
EP1847543A1
(de)
|
2006-04-19 |
2007-10-24 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Dihydrothienopyrimidine zur Behandlung von entzündlichen Erkrankungen
|
|
BRPI0710874A2
(pt)
|
2006-04-26 |
2012-02-14 |
Hoffmann La Roche |
compostos de tienopirimidina, processos de produção dos referidos compostos, composições farmacêuticas contendo os mesmos, kit, produto, e usos dos compostos
|
|
WO2007127175A2
(en)
*
|
2006-04-26 |
2007-11-08 |
F. Hoffmann-La Roche Ag |
Pharmaceutical compounds
|
|
TW200801012A
(en)
*
|
2006-04-26 |
2008-01-01 |
Piramed Ltd |
Phosphoinositide 3-kinase inhibitor compounds and methods of use
|
|
EP2114950B1
(de)
*
|
2006-12-07 |
2016-03-09 |
Genentech, Inc. |
Phosphoinositid-3-kinaseinhibitorverbindungen und anwendungsverfahren
|
|
AU2007329352B2
(en)
*
|
2006-12-07 |
2013-01-17 |
F. Hoffmann-La Roche Ag |
Phosphoinositide 3-kinase inhibitor compounds and methods of use
|
|
CA2705719C
(en)
*
|
2007-09-14 |
2016-10-11 |
Janssen Pharmaceutica N.V. |
Thieno-and furo-pyrimidine modulators of the histamine h4 receptor
|
|
ES2399774T3
(es)
|
2007-09-24 |
2013-04-03 |
Genentech, Inc. |
Compuestos de tiazolopirimidina inhibidores de PI3K y métodos de uso
|
|
JP5150728B2
(ja)
|
2007-10-19 |
2013-02-27 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
置換ピペリジノ−ジヒドロチエノピリミジン
|
|
EP2215093B1
(de)
|
2007-10-19 |
2011-12-14 |
Boehringer Ingelheim International GmbH |
Neue piperazino-dihydrothienopyrimidin-derivate
|
|
EP2205609B1
(de)
|
2007-10-19 |
2017-03-29 |
Boehringer Ingelheim International GmbH |
Heterocyclus-substituierte piperazino-dihydrothienopyrimidine
|
|
JP5348725B2
(ja)
|
2007-10-25 |
2013-11-20 |
ジェネンテック， インコーポレイテッド |
チエノピリミジン化合物の製造方法
|
|
GB0721095D0
(en)
*
|
2007-10-26 |
2007-12-05 |
Piramed Ltd |
Pharmaceutical compounds
|
|
AU2008323628B2
(en)
*
|
2007-11-15 |
2013-10-17 |
Ym Biosciences Australia Pty Ltd |
N-containing heterocyclic compounds
|
|
EP2405916B1
(de)
|
2009-03-12 |
2018-02-07 |
Genentech, Inc. |
Kombination von phosphoinositid 3-kinase inhibitor- verbindungen und chemiotherapeutischen mitteln für die behandlung von blutbildenden bösartigen tumoren
|
|
US8158625B2
(en)
*
|
2009-05-27 |
2012-04-17 |
Genentech, Inc. |
Bicyclic indole-pyrimidine PI3K inhibitor compounds selective for P110 delta, and methods of use
|
|
WO2010138589A1
(en)
*
|
2009-05-27 |
2010-12-02 |
Genentech, Inc. |
Bicyclic pyrimidine pi3k inhibitor compounds selective for p110 delta, and methods of use
|
|
PH12012500709A1
(en)
*
|
2009-10-12 |
2012-10-29 |
Hoffmann La Roche |
Combinations of a pi3k inhibitor and a mek inhibitor
|
|
BR112012026470A2
(pt)
|
2010-04-16 |
2016-08-09 |
Genentech Inc |
método para prever a sensibilidade de crescimento de células tumorais e para tratar um tumor em um paciente
|
|
US20140004209A1
(en)
|
2010-12-22 |
2014-01-02 |
Genentech, Inc. |
Autophagy inducer and inhibitor combination therapy for the treatment of neoplasms
|
|
US9802954B2
(en)
|
2011-08-24 |
2017-10-31 |
Boehringer Ingelheim International Gmbh |
Piperidino-dihydrothienopyrimidine sulfoxides and their use for treating COPD and asthma
|
|
US20130059866A1
(en)
|
2011-08-24 |
2013-03-07 |
Boehringer Ingelheim International Gmbh |
Novel piperidino-dihydrothienopyrimidine sulfoxides and their use for treating copd and asthma
|
|
FR2988722B1
(fr)
*
|
2012-04-03 |
2014-05-09 |
Sanofi Sa |
Nouveaux derives de thienopyrimidines, leurs procedes de preparation et leurs utilisations therapeutiques
|
|
JP6077642B2
(ja)
*
|
2012-04-10 |
2017-02-08 |
シャンハイ インリ ファーマシューティカル カンパニー リミティド |
縮合ピリミジン化合物、その調製法、中間体、組成物、及び使用
|
|
AR094873A1
(es)
|
2013-02-25 |
2015-09-02 |
Genentech Inc |
Métodos y composiciones para detectar y tratar mutantes de akt resistentes a fármacos
|
|
CN103242341B
(zh)
*
|
2013-04-19 |
2015-12-09 |
中国科学院广州生物医药与健康研究院 |
噻吩并2，4取代嘧啶类化合物及其药物组合物与应用
|
|
EP3053926B1
(de)
*
|
2013-09-30 |
2018-08-08 |
Shanghai Yingli Pharmaceutical Co. Ltd. |
Kondensierte pyrimidinverbindung, zwischenprodukt, herstellungsverfahren dafür und zusammensetzung und anwendung davon
|
|
RU2545758C1
(ru)
*
|
2014-03-20 |
2015-04-10 |
Общество с ограниченной ответственностью "Алион" |
Бициклические пиримидины или их фармацевтически приемлемые соли-активаторы антиоксидантной программы и их применение в качестве цитопротекторов
|
|
US10174032B2
(en)
*
|
2014-05-05 |
2019-01-08 |
Signalrx Pharmaceuticals, Inc. |
Heterocyclic compound classes for signaling modulation
|
|
GB201410816D0
(en)
*
|
2014-06-17 |
2014-07-30 |
Ucb Biopharma Sprl And Katholieke Universiteit Leuven |
Therapeutic agents
|
|
US10646490B2
(en)
|
2015-03-02 |
2020-05-12 |
University Of Maryland, Baltimore County |
Thieno- and pyrrolopyrimidine analogues and prodrugs thereof as anticancer agents and methods of use thereof
|
|
US9434742B1
(en)
*
|
2015-03-02 |
2016-09-06 |
University Of Maryland, Baltimore County |
Thieno- and pyrrolopyrimidine analogues as anticancer agents and methods of use thereof
|
|
EP3324974B1
(de)
*
|
2015-07-24 |
2022-06-08 |
University Of Louisville Research Foundation, Inc. |
Verbindungen, zusammensetzungen, verfahren zur behandlung von erkrankungen und verfahren zur zubereitung von verbindungen
|
|
DE102015012049A1
(de)
*
|
2015-09-15 |
2017-03-16 |
Merck Patent Gmbh |
Verbindungen als ASIC-Inhibitoren und deren Verwendungen
|
|
US10696688B2
(en)
|
2015-11-23 |
2020-06-30 |
Council Of Scientific & Industrial Research |
Fused pyrimidines as isoform selective phosphoinositide-3-kinase-alpha inhibitors and process for preparation thereof
|
|
SG11201804901WA
(en)
|
2015-12-22 |
2018-07-30 |
SHY Therapeutics LLC |
Compounds for the treatment of cancer and inflammatory disease
|
|
CN105820175B
(zh)
*
|
2016-04-13 |
2019-09-20 |
四川大学 |
一种噻吩并嘧啶类化合物及其制备方法和应用
|
|
CN107698603B
(zh)
|
2016-08-09 |
2022-04-08 |
南京红云生物科技有限公司 |
噻吩并嘧啶类化合物、其制备方法、药用组合物及其应用
|
|
GB201700814D0
(en)
|
2017-01-17 |
2017-03-01 |
Liverpool School Tropical Medicine |
Compounds
|
|
CA3066939A1
(en)
|
2017-06-21 |
2018-12-27 |
SHY Therapeutics LLC |
Compounds that interact with the ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease
|
|
WO2020132071A1
(en)
|
2018-12-19 |
2020-06-25 |
Shy Therapeutics. Llc |
Compounds that interact with the ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and f1brotic disease
|
|
EP3897651A4
(de)
*
|
2018-12-21 |
2022-09-21 |
University of Notre Dame du Lac |
Entdeckung von inhibitoren von bd-oxidase zur behandlung mykobakterieller erkrankungen
|
|
MX2021009667A
(es)
|
2019-02-13 |
2021-12-10 |
Ptc Therapeutics Inc |
Compuestos de tioeno[3,2-b] piridin-7-amina para tratar la disautonomía familiar.
|
|
US12398140B2
(en)
|
2019-02-13 |
2025-08-26 |
Ptc Therapeutics, Inc. |
Substituted pyrrolo [2,3-d]pyrimidines for treating familial dysautonomia
|
|
JP2024533264A
(ja)
*
|
2021-09-07 |
2024-09-12 |
ピーティーシー セラピューティクス， インコーポレイテッド |
神経原性疾患を処置するための方法
|
|
CN115991716B
(zh)
*
|
2021-10-19 |
2025-10-17 |
中国药科大学 |
嘧啶并环类化合物及其衍生物、制备方法、药物组合物和应用
|